• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ARX
Click for more information
0.92% 54.0¢

AROA BIOSURGERY LIMITED - Charts / Financials

Market Cap $185.8M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Aroa Biosurgery Limited is a soft-tissue regeneration company. It develops, manufactures,... Aroa Biosurgery Limited is a soft-tissue regeneration company. It develops, manufactures, sells, and distributes medical and surgical products to improve healing in complex wounds and soft tissue reconstruction. Its products are developed from the AROA extracellular matrix (ECM) technology platform, an extracellular matrix biomaterial derived from ovine forestomach. AROA ECM is an ECM biomaterial containing a rich and complex mix of biological molecules that is the building block for a range of soft tissue repair products. Its products include Endoform, Myriad Matrix, Myriad Morcells, Myriad Morcells Fine, and Reinforced Bioscaffolds. Endoform products support all phases of wound healing and are appropriate for use early in wound management to restore protease balance and advance healing to the proliferative phase. Myriad Matrix is an engineered ECM for soft tissue repair, reinforcement and complex wounds. Its subsidiaries are Aroa Biosurgery Incorporated and Mesynthes Nominee Limited.More

refresh Created with Sketch. REFRESH
Last update - 15.51pm 06/05/2024 (20 minute delay) ?
Day
Open 55.0¢   Day High 55.0¢   Day Low 53.0¢
Daily Volume 388837
Bids   Sellers
Number Price Volume   Number Price Volume
1 53.5¢ 4   1 54.5¢ 11062

Directors & Senior Management

Mr. Brian Ward Chief Executive Officer, Founder, Managing Director, Executive Director
Mr. James Agnew Chief Financial Officer, Joint Company Secretary
Dr. Barnaby C.H. May Chief Scientific Officer
Mr. Brad Adams Vice President - Commercial, USA
Mr. Rod Stanley Vice President - Manufacturing
Ms. Tracy Weimar Joint Company Secretary
Mr. James Neil McLean Independent Non-Executive Chairman of the Board
Mr. Philip McCaw Non-Executive Director
Dr. Catherine Mohr Non-Executive Director
Mr. John Flower Diddams Independent Non-Executive Director
Ms. Darla Hutton Independent Non-Executive Director

Data source: Refinitiv

(20min delay)
Last
54.0¢ 		Change
-0.005(0.92%) 		Mkt cap ! $185.8M
Open High Low Value Volume
55.0¢ 55.0¢ 53.0¢ $210.2K 388.8K

Buyers (Bids)

No. Vol. Price($)
1 4 53.5¢
 

Sellers (Offers)

Price($) Vol. No.
54.5¢ 11062 1
View Market Depth
Last trade - 16.10pm 06/05/2024 (20 minute delay) ?
Last
54.5¢ 		  Change
-0.005 ( 0.93 %)
Open High Low Volume
54.0¢ 55.5¢ 53.0¢ 112963
Last updated 15.51pm 06/05/2024 ?

Top Stories

Tamboran is listing on the NYSE, and Wall Street is paying attention

If you needed evidence that Tamboran Resources is bullish on the NT's Beetaloo Basin, look no further than its decision to list on the NYSE.
Maiden drilling at West Arunta hints at major IOCG system for Rincon Rincon Resources believes that drill core picked up from a maiden program of work at its West Arunta project in Western Australia indicates potential for a major iron oxide copper gold deposit.
Sold out signs go up for RIU Resources Roundup in Sydney More than 115 companies will be participating in this year's RIU Resources Roundup in Sydney.
Mantle Minerals to kick off drilling at Mt Berghaus in WA Mantle Minerals (ASX:MTL) has announced it's kicking off a 122-hole drill run on-site its Mt Berghaus acreage in Western Australia.
Westpac tracks lower in profits in first half of 2024, with a 16% yoy drop amid slowing economy Westpac Banking Corporation has reported a 16 percent drop in net profit (to $3.342 billion) for the first half of the 2024 financial year compared to the same time last year.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.